OPNT
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
OPNT
Delisted
OPNT was delisted on the 1st of March, 2023.
29 hedge funds and large institutions have $7.26M invested in Opiant Pharmaceuticals, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$363K | |
| 2 | +$168K | |
| 3 | +$102K | |
| 4 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
+$20.1K |
| 5 |
NFSG
Newbridge Financial Services Group
Boca Raton,
Florida
|
+$16K |
Top Sellers
| 1 | -$203K | |
| 2 | -$90K | |
| 3 | -$65.1K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$27.5K |
| 5 |
Morgan Stanley
New York
|
-$18K |